Top

Published in:

Open Access 01-12-2014 | Review

Impact of three genetic musculoskeletal diseases: a comparative synthesis of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfecta

Authors: Maman Joyce Dogba, Frank Rauch, Erin Douglas, Christophe Bedos

Published in: Health and Quality of Life Outcomes | Issue 1/2014

Abstract

Achondroplasia, Duchenne muscular dystrophy, and osteogenesis imperfecta are among the most frequent rare genetic disorders affecting the musculoskeletal system in children. Rare genetic disorders are severely disabling and can have substantial impacts on families, children, and on healthcare systems. This literature review aims to classify, summarize and compare these non-medical impacts of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfecta.

Available only for authorised users

Schieppati A, Henter JI, Daina E, Aperia A: Why rare diseases are an important medical and social issue. Lancet 2008, 371: 2039–2041. 10.1016/S0140-6736(08)60872-7CrossRefPubMed

Ayme S, Kole A, Groft S: Empowerment of patients: lessons from the rare diseases community. Lancet 2008, 371: 2048–2051. 10.1016/S0140-6736(08)60875-2CrossRefPubMed

Kole A, Faurisson F: The Voice of 12,000 Patients: Experiences and expectations of rare disease patients on diagnosis and care in Europe. Eurodis edition. 2009.

Wallander JL, Varni JW: Effects of pediatric chronic physical disorders on child and family adjustment. J Child Psychol Psychiatry 1998, 39: 29–46. 10.1017/S0021963097001741CrossRefPubMed

Anderson M, Elliott EJ, Zurynski YA: Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J Rare Dis 2013, 8: 22. 10.1186/1750-1172-8-22PubMedCentralCrossRefPubMed

Shahbazi S, Moghaddam-Banaem L, Ekhtesari F, Ala FA: Impact of inherited bleeding disorders on pregnancy and postpartum hemorrhage. Blood Coagul Fibrinolysis 2012, 23: 603–607. 10.1097/MBC.0b013e3283566af9CrossRefPubMed

Boekaerts M, Roder I: Stress, coping, and adjustment in children with a chronic disease: a review of the literature. Disabil Rehabil 1999, 21: 311–337. 10.1080/096382899297576CrossRefPubMed

Levac D, Colquhoun H, O'Brien KK: Scoping studies: advancing the methodology. Implement Sci 2010, 5: 69. 10.1186/1748-5908-5-69PubMedCentralCrossRefPubMed

Daudt HM, van Mossel C, Scott SJ: Enhancing the scoping study methodology: a large, inter-professional team's experience with Arksey and O'Malley's framework. BMC Med Res Methodol 2013, 13: 48. 10.1186/1471-2288-13-48PubMedCentralCrossRefPubMed

10.

Brien SE, Lorenzetti DL, Lewis S, Kennedy J, Ghali WA: Overview of a formal scoping review on health system report cards. Implementation Science 2010, 5: 2. 10.1186/1748-5908-5-2PubMedCentralCrossRefPubMed

11.

Arksey H, O'Malley L: Scoping studies: towards a methodological framework. Int J Soc Res Methodol 2005, 8: 19–32. 10.1080/1364557032000119616CrossRef

12.

Saldaña J: The Coding Manula for Qualitative Researchers. Sage Publications, Los Angeles; 2013.

13.

Ain MC, Abdullah MA, Ting BL, Skolasky RL, Carlisle ES, Schkrohowsky JG, Rigamonti D: Progression of low back and lower extremity pain in a cohort of patients with achondroplasia. J Neurosurg Spine 2010, 13: 335–340. 10.3171/2010.3.SPINE09629CrossRefPubMed

14.

Gollust SE, Thompson RE, Gooding HC, Biesecker BB: Living with achondroplasia: attitudes toward population screening and correlation with quality of life. Prenat Diagn 2003, 23: 1003–1008. 10.1002/pd.743CrossRefPubMed

15.

Kim S-J, Balce GC, Agashe MV, Song S-H, Song H-R: Is bilateral lower limb lengthening appropriate for Achondroplasia? Midterm analysis of the complications and quality of life. Clin Orthop Relat Res 2012, 470: 616–621. 10.1007/s11999-011-1983-yPubMedCentralCrossRefPubMed

16.

Abi Daoud MS, Dooley JM, Gordon KE: Depression in parents of children with Duchenne muscular dystrophy. Pediatr Neurol 2004, 31: 16–19. 10.1016/j.pediatrneurol.2004.01.011CrossRefPubMed

17.

Acharya K, Ackerman PD, Ross LF: Pediatricians' attitudes toward expanding newborn screening. Pediatrics 2005, 116: E476-E482. 10.1542/peds.2005-0453CrossRefPubMed

18.

Arias R, Andrews J, Pandya S, Pettit K, Trout C, Apkon S, Karwoski J, Cunniff C, Matthews D, Miller T, Davis MF, Meaney FJ: Palliative care services in families of males with Duchenne muscular dystrophy. Muscle Nerve 2011, 44: 93–101. 10.1002/mus.22005CrossRefPubMed

19.

Baiardini I, Minetti C, Bonifacino S, Porcu A, Klersy C, Petralia P, Balestracci S, Tarchino F, Parodi S, Canonica GW, Braido F: Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. J Child Neurol 2011, 26: 707–713. 10.1177/0883073810389043CrossRefPubMed

20.

Bendixen RM, Senesac C, Lott DJ, Vandenborne K: Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health. Health Qual Life Outcomes 2012, 10: 43. 10.1186/1477-7525-10-43PubMedCentralCrossRefPubMed

21.

Beresford BA, Sloper P: Chronically ill adolescents' experiences of communicating with doctors: a qualitative study. J Adolesc Health 2003, 33: 172–179. 10.1016/S1054-139X(03)00047-8CrossRefPubMed

22.

Bray P, Bundy AC, Ryan MM, North KN, Burns J: Health status of boys with Duchenne muscular dystrophy: a parent’s perspective. J Paediatr Child Health 2011, 47: 557–562. 10.1111/j.1440-1754.2011.02022.xCrossRefPubMed

23.

Bray P, Bundy AC, Ryan MM, North KN, Everett A: Health-related quality of life in boys with Duchenne muscular dystrophy: agreement between parents and their sons. J Child Neurol 2010, 25: 1188–1194. 10.1177/0883073809357624CrossRefPubMed

24.

Chen JY: Mediators affecting family function in families of children with Duchenne muscular dystrophy. Gaoxiong Yi Xue Ke Xue Za Zhi 2008, 24: 514–522.PubMed

25.

Chen JY, Chen SS, Jong YJ, Yang YH, Chang YY: A comparison of the stress and coping strategies between the parents of children with Duchenne muscular dystrophy and children with a fever. J Pediatr Nurs 2002, 17: 369–379. 10.1053/jpdn.2002.123525CrossRefPubMed

26.

Chen JY, Clark MJ: Family function in families of children with Duchenne muscular dystrophy. Fam Community Health 2007, 30: 296–304. 10.1097/01.FCH.0000290542.10458.f8CrossRefPubMed

27.

Chen J-Y, Clark M-J: Family resources and parental health in families of children with Duchenne muscular dystrophy. J Nurs Res 2010, 18: 239–248. 10.1097/JNR.0b013e3181fbe37bCrossRefPubMed

28.

Cyrulnik SE, Fee RJ, Batchelder A, Kiefel J, Goldstein E, Hinton VJ: Cognitive and adaptive deficits in young children with Duchenne muscular dystrophy (DMD). J Int Neuropsychol Soc 2008, 14: 853–861. 10.1017/S135561770808106XCrossRefPubMed

29.

Fee RJ, Hinton VJ: Resilience in children diagnosed with a chronic neuromuscular disorder. J Dev Behav Pediatr 2011, 32: 644–650. 10.1097/DBP.0b013e318235d614PubMedCentralCrossRefPubMed

30.

Firth M, Gardnermedwin D, Hosking G, Wilkinson E: Interviews with parents of boys suffering from Duchenne muscular-dystrophy. Dev Med Child Neurol 1983, 25: 466–471. 10.1111/j.1469-8749.1983.tb13791.xCrossRefPubMed

31.

Garralda ME, McConachie H, Le Couteur A, Sriranjan S, Chakrabarti I, Cirak S, Guglieri M, Bushby K, Muntoni F: Emotional impact of genetic trials in progressive paediatric disorders: a dose-ranging exon-skipping trial in Duchenne muscular dystrophy. Child Care Health Dev 2013, 39: 449–455. 10.1111/j.1365-2214.2012.01387.xCrossRefPubMed

32.

Garralda ME, Muntoni F, Cunniff A, Caneja AD: Knee-ankle-foot orthosis in children with duchenne muscular dystrophy: user views and adjustment. Eur J Paediatr Neurol 2006, 10: 186–191. 10.1016/j.ejpn.2006.07.002CrossRefPubMed

33.

Hanayama K, Liu M, Higuchi Y, Fujiwara T, Tsuji T, Hase K, Ishihara T: Dysphagia in patients with Duchenne muscular dystrophy evaluated with a questionnaire and videofluorography. Disabil Rehabil 2008, 30: 517–522. 10.1080/09638280701355595CrossRefPubMed

34.

Hendriksen JG, Poysky JT, Schrans DG, Schouten EG, Aldenkamp AP, Vles JS: Psychosocial adjustment in males with Duchenne muscular dystrophy: psychometric properties and clinical utility of a parent-report questionnaire. J Pediatr Psychol 2009, 34: 69–78. 10.1093/jpepsy/jsn067CrossRefPubMed

35.

James CA, Hadley DW, Holtzman NA, Winkelstein JA: How does the mode of inheritance of a genetic condition influence families? A study of guilt, blame, stigma, and understanding of inheritance and reproductive risks in families with X-linked and autosomal recessive diseases. Genet Med 2006, 8: 234–242. 10.1097/01.gim.0000215177.28010.6eCrossRefPubMed

36.

Jarvinen O, Lehesjoki AE, Lindlof M, Uutela A, Kaariainen H: Carrier testing of children for two X-linked diseases: a retrospective study of comprehension of the test results and social and psychological significance of the testing. Pediatrics 2000, 106: 1460–1465. 10.1542/peds.106.6.1460CrossRefPubMed

37.

Jutai J, Rigby P, Ryan S, Stickel S: Psychosocial impact of electronic aids to daily living. Assist Technol 2000, 12: 123–131. 10.1080/10400435.2000.10132018CrossRefPubMed

38.

Kemper AR, Wake MA: Duchenne muscular dystrophy: issues in expanding newborn screening. Curr Opin Pediatr 2007, 19: 700–704. 10.1097/MOP.0b013e3282f19f65CrossRefPubMed

39.

Kenneson A, Bobo JK: The effect of caregiving on women in families with Duchenne/Becker muscular dystrophy. Health Soc Care Community 2010, 18: 520–528. 10.1111/j.1365-2524.2010.00930.xCrossRefPubMed

40.

Kinali M, Manzur AY, Mercuri E, Gibson BE, Hartley L, Simonds AK, Muntoni F: UK physicians' attitudes and practices in long-term non-invasive ventilation of Duchenne Muscular Dystrophy. Pediatr Rehabil 2006, 9: 351–364.PubMed

41.

Kohler M, Clarenbach CF, Boeni L, Brack T, Russi EW, Bloch KE: Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med 2005, 172: 1032–1036. 10.1164/rccm.200503-322OCCrossRefPubMed

42.

Manzur AY, Kinali M, Muntoni F: Update on the management of Duchenne muscular dystrophy. Arch Dis Child 2008, 93: 986–990. 10.1136/adc.2007.118141CrossRefPubMed

43.

Marini A, Lorusso ML, D'Angelo MG, Civati F, Turconi AC, Fabbro F, Bresolin N: Evaluation of narrative abilities in patients suffering from Duchenne Muscular Dystrophy. Brain Lang 2007, 102: 1–12. 10.1016/j.bandl.2007.02.003CrossRefPubMed

44.

Pangalila RF, van den Bos GA, Stam HJ, van Exel NJ, Brouwer WB, Roebroeck ME: Subjective caregiver burden of parents of adults with Duchenne muscular dystrophy. Disabil Rehabil 2012, 34: 988–996. 10.3109/09638288.2011.628738CrossRefPubMed

45.

Parker AE, Robb SA, Chambers J, Davidson AC, Evans K, O'Dowd J, Williams AJ, Howard RS: Analysis of an adult Duchenne muscular dystrophy population. QJM 2005, 98: 729–736. 10.1093/qjmed/hci113CrossRefPubMed

46.

Parsons EP, Clarke AJ, Hood K, Lycett E, Bradley DM: Newborn screening for Duchenne muscular dystrophy: a psychosocial study. Arch Dis Child Fetal Neonatal Ed 2002, 86: F91-F95. 10.1136/fn.86.2.F91PubMedCentralCrossRefPubMed

47.

Pehler SR, Craft-Rosenberg M: Longing: the lived experience of spirituality in adolescents with Duchenne muscular dystrophy. J Pediatr Nurs 2009, 24: 481–494. 10.1016/j.pedn.2008.06.008PubMedCentralCrossRefPubMed

48.

Read J, Kinali M, Muntoni F, Garralda ME: Psychosocial adjustment in siblings of young people with Duchenne muscular dystrophy. Eur J Paediatr Neurol 2010, 14: 340–348. 10.1016/j.ejpn.2009.09.011CrossRefPubMed

49.

Read J, Kinali M, Muntoni F, Weaver T, Garralda ME: Siblings of young people with Duchenne muscular dystrophy - A qualitative study of impact and coping. Eur J Paediatr Neurol 2011, 15: 21–28. 10.1016/j.ejpn.2010.07.006CrossRefPubMed

50.

Simon VA, Resende MB, Simon MA, Zanoteli E, Reed UC: Duchenne muscular dystrophy: quality of life among 95 patients evaluated using the Life Satisfaction Index for Adolescents. Arq Neuropsiquiatr 2011, 69: 19–22. 10.1590/S0004-282X2011000100005CrossRefPubMed

51.

Steele M, Taylor E, Young C, McGrath P, Lyttle BD, Davidson B: Mental health of children and adolescents with Duchenne muscular dystrophy. Dev Med Child Neurol 2008, 50: 638–639. 10.1111/j.1469-8749.2008.03024.xCrossRefPubMed

52.

Uzark K, King E, Cripe L, Spicer R, Sage J, Kinnett K, Wong B, Pratt J, Varni JW: Health-related quality of life in children and adolescents with Duchenne muscular dystrophy. Pediatrics 2012, 130: E1559-E1566. 10.1542/peds.2012-0858CrossRefPubMed

53.

van Wijk E, Messelink BJ, Heijnen L, de Groot IJ: Prevalence and psychosocial impact of lower urinary tract symptoms in patients with Duchenne muscular dystrophy. Neuromuscul Disord 2009, 19: 754–758. 10.1016/j.nmd.2009.07.009CrossRefPubMed

54.

Vandervelde L, Van den Bergh PY, Goemans N, Thonnard JL: Activity limitations in patients with neuromuscular disorders: a responsiveness study of the ACTIVLIM questionnaire. Neuromuscul Disord 2009, 19: 99–103. 10.1016/j.nmd.2008.11.004CrossRefPubMed

55.

Balkefors V, Mattsson E, Pernow Y, Saaf M: Functioning and quality of life in adults with mild-to-moderate osteogenesis imperfecta. Physiother Res Int 2012, ᅟ: ᅟ.

56.

Bernehall Claesson I, Brodin J: What families with children with brittle bones want to tell. Child Care Health Dev 2002, 28: 309–315. 10.1046/j.1365-2214.2002.00282.xCrossRefPubMed

57.

Brodin J: Children and adolescents with brittle bones - psychosocial-aspects. Child Care Health Dev 1993, 19: 341–347. 10.1111/j.1365-2214.1993.tb00738.xCrossRefPubMed

58.

Cole DE: Psychosocial aspects of osteogenesis imperfecta: an update. Am J Med Genet 1993, 45: 207–211. 10.1002/ajmg.1320450211CrossRefPubMed

59.

Daly K, Wisbeach A, Sanpera I Jr, Fixsen JA: The prognosis for walking in osteogenesis imperfecta. J Bone Joint Surg Br 1996, 78: 477–480.PubMed

60.

Engelbert RH, Uiterwaal CS, Gulmans VA, Pruijs H, Helders PJ: Osteogenesis imperfecta in childhood: prognosis for walking. J Pediatr 2000, 137: 397–402. 10.1067/mpd.2000.107892CrossRefPubMed

61.

Kok DJ, Uiterwaal C, van Dongen AJ, Kramer PPG, Pruijs HEH, Engelbert RHH, Verbout AJ, Schweitzer DH, Sakkers RJB: The interaction between Sillence type and BMD in osteogenesis imperfecta. Calcif Tissue Int 2003, 73: 441–445. 10.1007/s00223-002-2101-7CrossRefPubMed

62.

Montpetit K, Dahan-Oliel N, Ruck-Gibis J, Fassier F, Rauch F, Glorieux F: Activities and participation in young adults with osteogenesis imperfecta. J Pediatr Rehabil Med 2011, 4: 13–22.PubMed

63.

Seikaly MG, Kopanati S, Salhab N, Waber P, Patterson D, Browne R, Herring JA: Impact of alendronate on quality of life in children with osteogenesis imperfecta. J Pediatr Orthop 2005, 25: 786–791. 10.1097/01.bpo.0000176162.78980.edCrossRefPubMed

64.

Suskauer SJ, Cintas HL, Marini JC, Gerber LH: Temperament and physical performance in children with Osteogenesis Imperfecta. Pediatrics 2003, 111: e153-e161. 10.1542/peds.111.2.e153CrossRefPubMed

65.

Szczepaniak-Kubat A, Kurnatowska O, Jakubowska-Pietkiewicz E, Chlebna-Sokol D: Assessment of quality of life of parents of children with Osteogenesis Imperfecta. Adv Clin Exp Med 2012, 21: 99–104.PubMed

66.

Tolboom N, Cats EA, Helders PJ, Pruijs JE, Engelbert RH: Osteogenesis imperfecta in childhood: effects of spondylodesis on functional ability, ambulation and perceived competence. Eur Spine J 2004, 13: 108–113. 10.1007/s00586-003-0574-3PubMedCentralCrossRefPubMed

67.

Van Brussel M, Takken T, Uiterwaal C, Pruijs HJ, Van der Net J, Helders PJM, Engelbert RHH: Physical training in children with osteogenesis imperfecta. J Pediatr 2008, 152: 111–116. 10.1016/j.jpeds.2007.06.029CrossRefPubMed

68.

Widmann R, Laplaza J, Bitan F, Brooks C, Root L: Quality of life in osteogenesis imperfecta. Int Orthop 2002, 26: 3–6. 10.1007/s002640100292PubMedCentralCrossRefPubMed

69.

Widmann RF, Bitan FD, Laplaza J, Burke SW, DiMaio MF, Schneider R: Spinal deformity, pulmonary compromise, and quality of life in osteogenesis imperfecta. Spine 1999, 24: 1673–1678. 10.1097/00007632-199908150-00008CrossRefPubMed

70.

Curran AL, Sharples PM, White C, Knapp M: Time costs of caring for children with severe disabilities compared with caring for children without disabilities. Dev Med Child Neurol 2001, 43: 529–533. 10.1017/S0012162201000962CrossRefPubMed

71.

van den Tweel XW, Hatzmann J, Ensink E, van der Lee JH, Peters M, Fijnvandraat K, Grootenhuis M: Quality of life of female caregivers of children with sickle cell disease: a survey. Haematologica 2008, 93: 588–593. 10.3324/haematol.11610CrossRefPubMed

72.

Zurynski Y, Frith K, Leonard H, Elliott E: Rare childhood diseases: how should we respond? Arch Dis Child 2008, 93: 1071–1074. 10.1136/adc.2007.134940CrossRefPubMed

73.

Dogba MJ, Bedos C, Durigova M, Montpetit K, Wong T, Glorieux F, Rauch F: The Impact of Severe Osteogenesis Imperfecta on the Lives of Young Patients and Their Parents – a Qualitative Analysis. BMC Pediatr 2013, 13: 153. 10.1186/1471-2431-13-153PubMedCentralCrossRefPubMed

74.

Ratliffe CE, Harrigan RC, Haley J, Tse A, Olson T: Stress in families with medically fragile children. Issues Compr Pediatr Nurs 2002, 25: 167–188. 10.1080/01460860290042558CrossRefPubMed

75.

Kazak AE, Reber M, Snitzer L: Childhood chronic disease and family functionning- a study of phenylketonuria. Pediatrics 1988, 81: 224–230.PubMed

76.

Battista RN, Blancquaert I, Laberge AM, van Schendel N, Leduc N: Genetics in health care: an overview of current and emerging models. Public Health Genomics 2012, 15: 34–45. 10.1159/000328846CrossRefPubMed

77.

Zurynski Y, Peadon E, Bower C, Elliott EJ: Impacts of national surveillance for uncommon conditions in childhood. J Paediatr Child Health 2007, 43: 724. 10.1111/j.1440-1754.2007.01216.xCrossRefPubMed

78.

Burton H, Sanderson S, Shortland G, Lee P: Needs assessment and review of services for people with inherited metabolic disease in the United Kingdom. J Inherit Metab Dis 2006, 29: 667–676. 10.1007/s10545-006-0374-0CrossRefPubMed

79.

Eiser C, Morse R: A review of measures of quality of life for children with chronic illness. Arch Dis Child 2001, 84: 205–211. 10.1136/adc.84.3.205PubMedCentralCrossRefPubMed

80.

Rajmil L, Perestelo-Perez L, Herdman M: Quality of life and rare diseases. Adv Exp Med Biol 2010, 686: 251–272. 10.1007/978-90-481-9485-8_15CrossRefPubMed

81.

Paterson CR, Rosalind MH: Life expectancy in osteogenesis imperfecta. Br Med J 1996, 312: 351. 10.1136/bmj.312.7027.351CrossRef

Title: Impact of three genetic musculoskeletal diseases: a comparative synthesis of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfecta
Authors: Maman Joyce Dogba
Frank Rauch
Erin Douglas
Christophe Bedos
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: Health and Quality of Life Outcomes / Issue 1/2014
Electronic ISSN: 1477-7525
DOI: https://doi.org/10.1186/s12955-014-0151-y

At a glance: The STEP trials

Springer Medicine

Impact of three genetic musculoskeletal diseases: a comparative synthesis of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfecta

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Falls and EQ-5D rated quality of life in community-dwelling seniors with concurrent chronic diseases: a cross-sectional study

Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine

Impact of Alzheimer’s Disease on Caregiver Questionnaire: internal consistency, convergent validity, and test-retest reliability of a new measure for assessing caregiver burden

Wellbeing among sub-Saharan African patients with advanced HIV and/or cancer: an international multicentred comparison study of two outcome measures

Validation of the Chinese version of the Reynolds’ suicidal ideation questionnaire: psychometric properties and its short version

Perceptions of symptoms and expectations of advanced therapy for Parkinson’s disease: preliminary report of a Patient-Reported Outcome tool for Advanced Parkinson’s disease (PRO-APD)